Patents by Inventor Rochelle Hanley

Rochelle Hanley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of thyroid beta-agonists
    Patent number: 11951114
    Abstract: Methods useful for treating X-linked adrenoleukodystrophy are provided.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: April 9, 2024
    Assignees: Viking Therapeutics, Inc., Metabasis Therapeutics, Inc.
    Inventors: Brian Lian, Rochelle Hanley, Misha Dinerman, Mark Erion, Serge Boyer, Hongjian Jiang
  • USE OF THYROID BETA-AGONISTS
    Publication number: 20220257618
    Abstract: Methods useful for treating X-linked adrenoleukodystrophy are provided.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Inventors: BRIAN LIAN, Rochelle Hanley, Misha Dinerman, Mark Erion, Serge Boyer, Hongjian Jiang
  • Use of thyroid beta-agonists
    Patent number: 11351183
    Abstract: Methods useful for treating X-linked adrenoleukodystrophy are provided.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: June 7, 2022
    Assignees: Viking Therapeutics, Inc., Metabasis Therapeutics, Inc.
    Inventors: Brian Lian, Rochelle Hanley, Misha Dinerman, Mark Erion, Serge Boyer, Hongjian Jiang
  • METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
    Publication number: 20200060991
    Abstract: A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
    Type: Application
    Filed: November 1, 2019
    Publication date: February 27, 2020
    Inventors: Robert L. Zerbe, Alexander Bridges, Risto Lammintausta, Rochelle Hanley, Stuart Dombey
  • Methods for the treatment of erectile dysfunction using fispemifene
    Patent number: 10500166
    Abstract: A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
    Type: Grant
    Filed: March 21, 2013
    Date of Patent: December 10, 2019
    Assignee: QUATRX PHARMACEUTICALS
    Inventors: Robert L. Zerbe, Alexander Bridges, Risto Lammintausta, Rochelle Hanley, Stuart Dombey
  • USE OF THYROID BETA-AGONISTS
    Publication number: 20190321379
    Abstract: Methods useful for treating X-linked adrenoleukodystrophy are provided.
    Type: Application
    Filed: April 24, 2017
    Publication date: October 24, 2019
    Inventors: Brian Lian, Rochelle Hanley, Misha Dinerman, Mark Erion, Serge Boyer, Hongjian Jiang
  • USE OF THYROID BETA-AGONISTS
    Publication number: 20190134069
    Abstract: Methods useful for treating X-linked adrenoleukodystrophy are provided.
    Type: Application
    Filed: April 24, 2017
    Publication date: May 9, 2019
    Inventors: Brian Lian, Rochelle Hanley, Misha Dinerman
  • METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
    Publication number: 20130217696
    Abstract: A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
    Type: Application
    Filed: March 21, 2013
    Publication date: August 22, 2013
    Applicant: QuatRX Pharmaceuticals Company
    Inventors: Robert L. Zerbe, Alexander Bridges, Risto Lammintausta, Rochelle Hanley, Stuart Dombey
  • METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
    Publication number: 20100261729
    Abstract: A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
    Type: Application
    Filed: June 8, 2010
    Publication date: October 14, 2010
    Applicant: QUATRX PHARMACEUTICALS COMPANY
    Inventors: Robert L. Zerbe, Alexander Bridges, Risto Lammintausta, Rochelle Hanley, Stuart Dombey
  • METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
    Publication number: 20080312239
    Abstract: A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
    Type: Application
    Filed: June 13, 2008
    Publication date: December 18, 2008
    Applicant: QUATRX PHARMACEUTICALS COMPANY
    Inventors: Robert L. Zerbe, Alexander Bridges, Risto Lammintausta, Rochelle Hanley, Stuart Dombey
  • Method for preventing and treating skin aging
    Publication number: 20020197286
    Abstract: Skin aging and acne are prevented and treated with a composition comprising an estrogen and a progestin.
    Type: Application
    Filed: December 5, 2001
    Publication date: December 26, 2002
    Inventors: Jane Brandman, Rochelle Hanley